首页 › 多发性骨髓瘤 › 哥伦比亚特区 › Washington
Washington DC 多发性骨髓瘤临床试验
22项针对 多发性骨髓瘤的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
招募中3 期
- Research Site, Washington D.C.
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Tissue Collection for Studies of Lymph Cancer
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
招募中4 期
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 距离 7 英里
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
招募中3 期
- Center for Cancer and Blood Disorders, Bethesda · 距离 7 英里
18F-Fluciclovine PET/CT in Multiple Myeloma
招募中2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 距离 7 英里
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
招募中2 期
- Lombardi Comprehensive Cancer Center, Washington D.C.
Collection of Tissue Samples for Cancer Research
招募中观察性研究
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
招募中3 期
- Georgetown University Medical Center, Washington D.C.
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
招募中3 期
- MedStar Washington Hospital Center MedStar Georgetown Cancer Institute, Washington D.C.
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
招募中2 期
- GSK Investigational Site, Bethesda · 距离 7 英里
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
招募中3 期
- Sibley Memorial Hospital, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
招募中
- Georgetown University School of Medicine, Washington D.C.
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- Maryland Oncology Hematology - Silver Spring /ID# 268562, Silver Spring · 距离 7 英里
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
招募中1/2 期
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 距离 7 英里
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
招募中3 期
- Sibley Memorial Hospital, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
招募中观察性研究欢迎健康志愿者
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
招募中3 期
- GSK Investigational Site, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
其他城市的 多发性骨髓瘤试验
- New York City, NY60 项研究
- Atlanta, GA42 项研究
- Boston, MA42 项研究
- Houston, TX38 项研究
- Durham, NC37 项研究
- Nashville, TN32 项研究
- Denver, CO27 项研究
- Rochester, MN24 项研究
- St. Louis, MO24 项研究
- Columbus, OH24 项研究
- Baldwin Park, CA23 项研究
- Edison, NJ22 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 肺癌41 项研究
- 前列腺癌38 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 卵巢癌23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。